Our government supported 300,000 researchers at 2,500 university medical centers such as the Hospital of the University of ...

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

This seemingly unrelated health issue could have a serious impact on a person's future risk of developing dementia ...

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...

Perimenopause affects every major organ system in the body. Follow these expert-approved tips to extend your healthspan.

Over 150 million people will be living with dementia by 2050, estimates suggest--more than double the number today.

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is so confusing. I have early Alzheimer's and have trouble organizing my ...

The second theory, which is newer, suggests that Alzheimer’s may be caused by problems with how cells in the brain produce ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...